Breaking News Instant updates and real-time market news.

AMT

American Tower

$237.87 /

+7.52 (+3.26%)

, ARNA

Arena Pharmaceuticals

$51.22 /

-1.7 (-3.21%)

08:25
09/04/19
09/04
08:25
09/04/19
08:25

Wells Fargo to hold a conference

2019 Wells Fargo Healthcare Conference will be held in Boston on September 4-5 with webcasted company presentations to begin on September 4 at 8:30 am; not all company presentations may be webcasted. Webcast Link

AMT

American Tower

$237.87 /

+7.52 (+3.26%)

ARNA

Arena Pharmaceuticals

$51.22 /

-1.7 (-3.21%)

ADAP

Adaptimmune

$1.55 /

-0.06 (-3.73%)

AFMD

Affimed N.V.

$2.76 /

-0.01 (-0.36%)

TFX

Teleflex

$360.77 /

-2.92 (-0.80%)

EOLS

Evolus

$16.10 /

-1.07 (-6.23%)

TPTX

Turning Point Therapeutics

$51.20 /

-3.21 (-5.90%)

SNSS

Sunesis

$0.97 /

+0.14 (+16.87%)

SIEN

Sientra

$6.33 /

-0.5 (-7.32%)

HALO

Halozyme

$16.16 /

-0.37 (-2.24%)

GMED

Globus Medical

$49.60 /

-1.47 (-2.88%)

BDX

Becton Dickinson

$248.19 /

-5.56 (-2.19%)

GTS

Triple-S

$19.96 /

-0.62 (-3.01%)

IMMU

Immunomedics

$12.58 /

-0.21 (-1.64%)

TBPH

Theravance Biopharma

$21.47 /

-0.57 (-2.59%)

SEM

Select Medical

$16.03 /

-0.185 (-1.14%)

NUVA

NuVasive

$63.06 /

-0.43 (-0.68%)

MMSI

Merit Medical

$34.13 /

-0.65 (-1.87%)

INFI

Infinity Pharmaceuticals

$1.16 /

+0.01 (+0.87%)

EBS

Emergent BioSolutions

$50.21 /

+6.37 (+14.53%)

CALA

Calithera Biosciences

$3.92 /

-0.075 (-1.88%)

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 09

    Sep

  • 09

    Sep

  • 19

    Sep

  • 25

    Sep

  • 27

    Sep

  • 23

    Oct

  • 13

    Nov

  • 06

    Sep

AMT American Tower
$237.87 /

+7.52 (+3.26%)

08/19/19 KeyBanc
American Tower price target raised to $253 from $225 at KeyBanc
08/01/19 SunTrust
American Tower price target raised to $230 from $210 at SunTrust
08/01/19 JPMorgan
JPMorgan upgrades Crown Castle to Overweight, downgrades SBA to Neutral
07/15/19 KeyBanc
American Tower price target raised to $225 from $207 at KeyBanc
ARNA Arena Pharmaceuticals
$51.22 /

-1.7 (-3.21%)

04/03/19 Credit Suisse
Arena Pharmaceuticals price target raised to $77 from $63 at Credit Suisse
01/29/19
Fly Intel: Top five analyst initiations
01/29/19 Cantor Fitzgerald
Arena Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
12/13/18 Berenberg
Arena Pharmaceuticals initiated with a Buy at Berenberg
ADAP Adaptimmune
$1.55 /

-0.06 (-3.73%)

08/02/19
Fly Intel: Top five analyst downgrades
08/02/19 Guggenheim
Adaptimmune downgraded to Neutral on low near-term visibility at Guggenheim
08/01/19 Guggenheim
Adaptimmune downgraded to Neutral from Buy at Guggenheim
07/29/19
Adaptimmune management to meet with Morgan Stanley
AFMD Affimed N.V.
$2.76 /

-0.01 (-0.36%)

03/28/19 SVB Leerink
Affimed N.V. initiated with an Outperform at SVB Leerink
10/09/18 BMO Capital
Affimed N.V.'s clinical trial hold on AFM11 'likely temporary', says BMO Capital
10/09/18 SunTrust
Affimed N.V. price target lowered to $5 from $7 at SunTrust
09/11/18 Wells Fargo
Amgen's AMG420 risk overstated, says Wells Fargo
TFX Teleflex
$360.77 /

-2.92 (-0.80%)

08/05/19 JMP Securities
Teleflex price target raised to $395 from $325 at JMP Securities
08/05/19 JMP Securities
Teleflex price target raised to $395 from $325 at JMP Securities
08/02/19 Needham
Teleflex price target raised to $403 from $325 at Needham
06/20/19 Raymond James
Teleflex voluntary recall manageable, says Raymond James
EOLS Evolus
$16.10 /

-1.07 (-6.23%)

08/13/19 JMP Securities
Evolus price target lowered to $30 from $35 at JMP Securities
07/31/19 Stifel
Physician survey bodes well for Evolus and Revance, says Stifel
07/11/19 Wells Fargo
Market right in seeing rebate news as risk to pharmaceuticals, says Wells Fargo
07/11/19 Wells Fargo
Evolus investors should keep eye on progressing Korean case, says Wells Fargo
TPTX Turning Point Therapeutics
$51.20 /

-3.21 (-5.90%)

09/04/19 Wells Fargo
Turning Point Therapeutics price target raised to $62 from $53 at Wells Fargo
07/24/19
Fly Intel: Top five analyst initiations
07/24/19 Guggenheim
Turning Point Therapeutics initiated with a Buy at Guggenheim
05/13/19
Fly Intel: Top five analyst initiations
SNSS Sunesis
$0.97 /

+0.14 (+16.87%)

12/20/18 H.C. Wainwright
Sunesis initiated with a Neutral at H.C. Wainwright
SIEN Sientra
$6.33 /

-0.5 (-7.32%)

08/09/19 Wells Fargo
Sientra setup favorable into second half, says Wells Fargo
07/25/19 Craig-Hallum
Sientra price target lowered to $14 from $20 at Craig-Hallum
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
HALO Halozyme
$16.16 /

-0.37 (-2.24%)

07/01/19 Cantor Fitzgerald
Halozyme price target raised to $27 from $24 at Cantor Fitzgerald
02/05/19 Piper Sandler
Piper says argenx cusatuzumab study could enable registration if responses hold
01/11/19 Wells Fargo
Halozyme undervalued relative to 'de -risked' assets, says Wells Fargo
11/27/18 JMP Securities
Halozyme Phase 3 trial amendment makes sense, says JMP Securities
GMED Globus Medical
$49.60 /

-1.47 (-2.88%)

07/09/19 Cantor Fitzgerald
Globus Medical shares attractive at current levels, says Cantor Fitzgerald
05/24/19 Wells Fargo
Wells Fargo downgrade Globus Medical on increased spinal robotics competition
05/24/19 Wells Fargo
Globus Medical downgraded to Market Perform from Outperform at Wells Fargo
02/28/19
Fly Intel: Top five analyst upgrades
BDX Becton Dickinson
$248.19 /

-5.56 (-2.19%)

08/06/19 Piper Sandler
Becton Dickinson price target lowered to $266 from $267 at Piper Jaffray
06/21/19 Argus
FDA advisory committee review of Becton Dickinson's DCB's a positive, says Argus
05/13/19
Fly Intel: Top five analyst upgrades
05/13/19 Wells Fargo
Becton Dickinson price target lowered to $265 from $280 at Wells Fargo
GTS Triple-S
$19.96 /

-0.62 (-3.01%)

IMMU Immunomedics
$12.58 /

-0.21 (-1.64%)

08/20/19
Fly Intel: Top five analyst initiations
08/20/19 Cantor Fitzgerald
Cantor Fitzgerald starts Immunomedics at Overweight, sees approval forthcoming
08/19/19 Cantor Fitzgerald
Immunomedics initiated with an Overweight at Cantor Fitzgerald
05/09/19 Piper Sandler
Immunomedics refiling timeline should bring some relief, says Piper Jaffray
TBPH Theravance Biopharma
$21.47 /

-0.57 (-2.59%)

08/16/19 Cantor Fitzgerald
Rinvoq read through 'very positive' for Theravance, says Cantor Fitzgerald
07/31/19 Piper Sandler
Theravance pipeline receiving 'very little credit,' says Piper Jaffray
06/19/19 Piper Sandler
Piper reiterates $55 price target on Theravance after 'positive' data
06/07/19 Piper Sandler
Theravance recent selloff brings buying opportunity, says Piper Jaffray
SEM Select Medical
$16.03 /

-0.185 (-1.14%)

05/17/19 JMP Securities
Select Medical upgraded to Outperform with $18 price target at JMP Securities
05/17/19 JMP Securities
Select Medical upgraded to Outperform from Market Perform at JMP Securities
12/14/18 Barclays
Select Medical initiated with an Equal Weight at Barclays
10/16/18 Credit Suisse
Select Medical initiated with a Neutral at Credit Suisse
NUVA NuVasive
$63.06 /

-0.43 (-0.68%)

08/09/19 BMO Capital
NuVasive price target raised to $68 from $54 at BMO Capital
07/29/19 Baird
NuVasive downgraded to Neutral at Baird
07/29/19 Baird
NuVasive downgraded to Neutral from Outperform at Baird
MMSI Merit Medical
$34.13 /

-0.65 (-1.87%)

08/15/19 Piper Sandler
Merit Medical remains a favorite mid cap idea at Piper Jaffray
07/26/19 Needham
Merit Medical downgraded to Hold from Buy at Needham
07/26/19 Wells Fargo
Wells Fargo downgrades Merit Medical on lack of earnings visibility
07/26/19 Wells Fargo
Merit Medical downgraded to Market Perform from Outperform at Wells Fargo
INFI Infinity Pharmaceuticals
$1.16 /

+0.01 (+0.87%)

06/27/19
Fly Intel: Top five analyst initiations
06/27/19
Oppenheimer bullish on Infinity Pharmaceuticals, initiates with an Outperform
06/26/19 Oppenheimer
Infinity Pharmaceuticals initiated with an Outperform at Oppenheimer
02/26/19 JonesTrading
Infinity Pharmaceuticals initiated with a Buy at JonesTrading
EBS Emergent BioSolutions
$50.21 /

+6.37 (+14.53%)

09/04/19 Wells Fargo
Wells Fargo upgrades Emergent BioSolutions after 'major' contact win
09/04/19 Wells Fargo
Emergent BioSolutions upgraded to Outperform from Market Perform at Wells Fargo
06/03/19 Wells Fargo
Size, timeline of Emergent new contract 'a clear positive,' says Wells Fargo
05/09/19 Wells Fargo
Emergent BioSolutions price target lowered to $61 from $68 at Wells Fargo
CALA Calithera Biosciences
$3.92 /

-0.075 (-1.88%)

05/30/19 Citi
Calithera Biosciences assumed with a Buy at Citi

TODAY'S FREE FLY STORIES

Hot Stocks
NIO Inc. reports 3,533 vehicles in July » 05:36
08/03/20
08/03
05:36
08/03/20
05:36
NIO

NIO Inc.

$11.95 /

-0.245 (-2.01%)

NIO Inc. provided its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO Inc.
$11.95 /

-0.245 (-2.01%)

NIO NIO Inc.
$11.95 /

-0.245 (-2.01%)

07/21/20 CICC
NIO Inc. upgraded to Outperform from Neutral at CICC
07/17/20
Fly Intel: Top five analyst downgrades
07/17/20 Goldman Sachs
NIO Inc. downgraded to Sell from Neutral at Goldman Sachs
07/16/20 Deutsche Bank
Nikola initiated with a Hold at Deutsche Bank
NIO NIO Inc.
$11.95 /

-0.245 (-2.01%)

  • 11
    Jun
NIO NIO Inc.
$11.95 /

-0.245 (-2.01%)

NIO NIO Inc.
$11.95 /

-0.245 (-2.01%)

NIO NIO Inc.
$11.95 /

-0.245 (-2.01%)

Hot Stocks
Bilibili announces 3-year strategic partnership with Riot Games » 05:35
08/03/20
08/03
05:35
08/03/20
05:35
BILI

Bilibili

$43.58 /

+2.31 (+5.60%)

Bilibili said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BILI Bilibili
$43.58 /

+2.31 (+5.60%)

BILI Bilibili
$43.58 /

+2.31 (+5.60%)

07/17/20 BOCOM
Bilibili downgraded to Neutral from Buy at BOCOM
05/27/20 Morgan Stanley
Bilibili upgraded to Overweight from Equal Weight at Morgan Stanley
05/21/20 JPMorgan
JPMorgan upgrades Bilibili to Overweight with Street-high $42 target
05/21/20 JPMorgan
Bilibili upgraded to Overweight from Neutral at JPMorgan
BILI Bilibili
$43.58 /

+2.31 (+5.60%)

BILI Bilibili
$43.58 /

+2.31 (+5.60%)

BILI Bilibili
$43.58 /

+2.31 (+5.60%)

Hot Stocks
Aslan Pharmaceuticals appoints Kenneth Kobayashi, MD, as Chief Medical Officer » 05:33
08/03/20
08/03
05:33
08/03/20
05:33
ASLN

Aslan Pharmaceuticals

$1.54 /

-0.065 (-4.06%)

ASLAN Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASLN Aslan Pharmaceuticals
$1.54 /

-0.065 (-4.06%)

ASLN Aslan Pharmaceuticals
$1.54 /

-0.065 (-4.06%)

04/13/20 Piper Sandler
Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler
03/18/20 Piper Sandler
Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler
12/10/19 H.C. Wainwright
Aslan Pharmaceuticals price target raised to $5 from $2 at H.C. Wainwright
12/02/19 Piper Jaffray
Piper upgrades Aslan to Overweight with $8 target after atopic dermatitis data
ASLN Aslan Pharmaceuticals
$1.54 /

-0.065 (-4.06%)

  • 04
    Dec
Earnings
Kosmos reports Q2 adj. EPS (23c), consensus (33c) » 05:31
08/03/20
08/03
05:31
08/03/20
05:31
KOS

Kosmos

$1.61 /

+0.03 (+1.90%)

Reports Q2 revenue $127M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KOS Kosmos
$1.61 /

+0.03 (+1.90%)

KOS Kosmos
$1.61 /

+0.03 (+1.90%)

05/14/20 Goldman Sachs
Kosmos downgraded to Neutral from Buy at Goldman Sachs
05/13/20 Berenberg
Kosmos price target lowered to $3.45 from $3.60 at Berenberg
05/13/20 RBC Capital
Kosmos upgraded to Sector Perform from Underperform at RBC Capital
04/29/20 Berenberg
Kosmos price target lowered to $3.60 from $9 at Berenberg
KOS Kosmos
$1.61 /

+0.03 (+1.90%)

KOS Kosmos
$1.61 /

+0.03 (+1.90%)

Hot Stocks
Hudson to lay off 40% of workforce, announces COVID-19 update » 05:29
08/03/20
08/03
05:29
08/03/20
05:29
HUD

Hudson

$4.37 /

+0.035 (+0.81%)

Hudson said in its Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUD Hudson
$4.37 /

+0.035 (+0.81%)

HUD Hudson
$4.37 /

+0.035 (+0.81%)

03/19/20 Morgan Stanley
Morgan Stanley lowers targets for Gap, Macy's, and four other levered retailers
02/04/20 UBS
Hudson downgraded to Neutral from Buy at UBS
11/05/19
Fly Intel: Top five analyst downgrades
11/05/19 BofA/Merrill
Hudson downgraded to Underperform from Neutral at BofA/Merrill
HUD Hudson
$4.37 /

+0.035 (+0.81%)

HUD Hudson
$4.37 /

+0.035 (+0.81%)

Upgrade
Seven & i Holdings upgraded to Buy from Hold at Jefferies » 05:27
08/03/20
08/03
05:27
08/03/20
05:27
SVNDY

Seven & i Holdings

$0.00 /

+ (+0.00%)

Jefferies analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Merck upgraded to Buy from Neutral at Goldman Sachs » 05:25
08/03/20
08/03
05:25
08/03/20
05:25
MRK

Merck

$80.26 /

+1.21 (+1.53%)

Goldman Sachs analyst…

Goldman Sachs analyst Terence Flynn upgraded Merck & Co. to Buy from Neutral with a price target of $105, up from $91. The stock closed Friday up $1.25 to $80.24. The analyst's positive outlook on the shares consists of pipeline and balance sheet "optionality." The market is ascribing minimal value to Merck's potential opportunity of $13B-$18B in pipeline assets, Flynn tells investors in a research note. The analyst views the stock's risk/reward as attractive heading into a number of upcoming readouts later this year and into next for cancer, HIV and COVID-19. Meanwhile, Merck has $45B of "firepower" to be more active on the acquisition or business development front as the company paused its share repurchase program earlier this year, says Flynn. The analyst also believes Keytruda loss of exclusivity "tail risk" is priced into the stock.

ShowHide Related Items >><<
MRK Merck
$80.26 /

+1.21 (+1.53%)

MRK Merck
$80.26 /

+1.21 (+1.53%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 H.C. Wainwright
Agreement termination 'optimal' for Vyleesi future, says H.C. Wainwright
06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
MRK Merck
$80.26 /

+1.21 (+1.53%)

MRK Merck
$80.26 /

+1.21 (+1.53%)

MRK Merck
$80.26 /

+1.21 (+1.53%)

MRK Merck
$80.26 /

+1.21 (+1.53%)

Earnings
Hudson reports Q2 EPS (85c), consensus (66c) » 05:23
08/03/20
08/03
05:23
08/03/20
05:23
HUD

Hudson

$4.37 /

+0.035 (+0.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUD Hudson
$4.37 /

+0.035 (+0.81%)

HUD Hudson
$4.37 /

+0.035 (+0.81%)

03/19/20 Morgan Stanley
Morgan Stanley lowers targets for Gap, Macy's, and four other levered retailers
02/04/20 UBS
Hudson downgraded to Neutral from Buy at UBS
11/05/19
Fly Intel: Top five analyst downgrades
11/05/19 BofA/Merrill
Hudson downgraded to Underperform from Neutral at BofA/Merrill
HUD Hudson
$4.37 /

+0.035 (+0.81%)

HUD Hudson
$4.37 /

+0.035 (+0.81%)

Downgrade
Redfin downgraded to Neutral from Buy at Compass Point » 05:19
08/03/20
08/03
05:19
08/03/20
05:19
RDFN

Redfin

$41.62 /

-1.32 (-3.07%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDFN Redfin
$41.62 /

-1.32 (-3.07%)

RDFN Redfin
$41.62 /

-1.32 (-3.07%)

07/28/20
Fly Intel: Top five analyst downgrades
07/28/20 Susquehanna
Redfin downgraded to Negative on valuation at Susquehanna
07/28/20 Susquehanna
Redfin downgraded to Negative from Neutral at Susquehanna
07/27/20 Zelman
Redfin upgraded to Buy from Hold at Zelman
RDFN Redfin
$41.62 /

-1.32 (-3.07%)

RDFN Redfin
$41.62 /

-1.32 (-3.07%)

RDFN Redfin
$41.62 /

-1.32 (-3.07%)

Hot Stocks
Tailored Brands files voluntary Chapter 11 petitions » 05:19
08/03/20
08/03
05:19
08/03/20
05:19
TLRD

Tailored Brands

$0.30 /

-0.081 (-21.05%)

Tailored Brands said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

03/19/20 Deutsche Bank
Tailored Brands price target lowered to $1 from $4 at Deutsche Bank
TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

Initiation
CLS Holdings initiated with a Buy at Panmure Gordon » 05:19
08/03/20
08/03
05:19
08/03/20
05:19
CLSH

CLS Holdings

$0.00 /

+ (+0.00%)

Panmure Gordon initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLSH CLS Holdings
$0.00 /

+ (+0.00%)

04/28/20 Canaccord
CLS Holdings downgraded to Hold at Canaccord
04/28/20 Canaccord
CLS Holdings downgraded to Hold from Speculative Buy at Canaccord
Upgrade
Varian upgraded to In Line from Underperform at Evercore ISI » 05:18
08/03/20
08/03
05:18
08/03/20
05:18
VAR

Varian

$142.44 /

+3.9 (+2.82%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VAR Varian
$142.44 /

+3.9 (+2.82%)

VAR Varian
$142.44 /

+3.9 (+2.82%)

08/02/20 Piper Sandler
Varian downgraded to Neutral from Overweight at Piper Sandler
07/27/20 Piper Sandler
Varian Medical price target raised to $142 from $130 at Piper Sandler
06/18/20 UBS
Varian Medical competitive position remains strong, says UBS
05/12/20 Piper Sandler
Piper Sandler notes goodwill impairment charge for Varian Medical investors
VAR Varian
$142.44 /

+3.9 (+2.82%)

Downgrade
ASE Technology downgraded to Neutral from Outperform at Credit Suisse » 05:17
08/03/20
08/03
05:17
08/03/20
05:17
ASX

ASE Technology

$5.01 /

-0.105 (-2.05%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASX ASE Technology
$5.01 /

-0.105 (-2.05%)

12/05/19 JPMorgan
ASE Technology upgraded to Overweight from Neutral at JPMorgan
09/23/19 Morgan Stanley
ASE Technology downgraded to Equal Weight from Overweight at Morgan Stanley
09/04/19
Fly Intel: Top five analyst initiations
09/04/19 Goldman Sachs
ASE Technology initiated with a Buy at Goldman Sachs
ASX ASE Technology
$5.01 /

-0.105 (-2.05%)

Hot Stocks
Tailored Brands files voluntary Chapter 11 petitions  05:17
08/03/20
08/03
05:17
08/03/20
05:17
TLRD

Tailored Brands

$0.30 /

-0.081 (-21.05%)

 
ShowHide Related Items >><<
TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

03/19/20 Deutsche Bank
Tailored Brands price target lowered to $1 from $4 at Deutsche Bank
TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

TLRD Tailored Brands
$0.30 /

-0.081 (-21.05%)

Upgrade
MoneyGram upgraded to In Line from Underperform at Evercore ISI » 05:17
08/03/20
08/03
05:17
08/03/20
05:17
MGI

MoneyGram

$3.46 /

-0.325 (-8.59%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGI MoneyGram
$3.46 /

-0.325 (-8.59%)

MGI MoneyGram
$3.46 /

-0.325 (-8.59%)

06/10/20
Fly Intel: Top five analyst downgrades
06/10/20 BofA
Western Union downgraded to Neutral from Buy at BofA
06/02/20 BTIG
Western Union-Money Gram review could note more online competition, says BTIG
04/06/20 Barclays
MoneyGram price target lowered to $1 from $2 at Barclays
MGI MoneyGram
$3.46 /

-0.325 (-8.59%)

MGI MoneyGram
$3.46 /

-0.325 (-8.59%)

MGI MoneyGram
$3.46 /

-0.325 (-8.59%)

MGI MoneyGram
$3.46 /

-0.325 (-8.59%)

Upgrade
Engie SA upgraded to Buy from Hold at HSBC » 05:16
08/03/20
08/03
05:16
08/03/20
05:16
ENGIY

Engie SA

$0.00 /

+ (+0.00%)

HSBC analyst Adam Dickens…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENGIY Engie SA
$0.00 /

+ (+0.00%)

ENGIY Engie SA
$0.00 /

+ (+0.00%)

07/17/20 Deutsche Bank
Engie SA price target raised to EUR 12 from EUR 10 at Deutsche Bank
07/08/20 Morgan Stanley
Engie SA price target raised to EUR 13 from EUR 12 at Morgan Stanley
06/25/20 UBS
Engie SA price target raised to EUR 10.75 from EUR 9.85 at UBS
05/13/20 Morgan Stanley
Engie SA upgraded to Overweight from Equal Weight at Morgan Stanley
ENGIY Engie SA
$0.00 /

+ (+0.00%)

ENGIY Engie SA
$0.00 /

+ (+0.00%)

Hot Stocks
Pretium Resources reports fatality at Brucejack Mine » 05:15
08/03/20
08/03
05:15
08/03/20
05:15
PVG

Pretium Resources

$9.47 /

+0.11 (+1.18%)

Pretium Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PVG Pretium Resources
$9.47 /

+0.11 (+1.18%)

PVG Pretium Resources
$9.47 /

+0.11 (+1.18%)

07/20/20 Scotiabank
Pretium Resources price target raised to C$12 from C$11 at Scotiabank
05/04/20 BMO Capital
Pretium Resources price target raised to C$13 from C$12 at BMO Capital
03/13/20 Roth Capital
Pretium Resources upgraded to Buy from Neutral at Roth Capital
02/13/20
Fly Intel: Top five analyst downgrades
PVG Pretium Resources
$9.47 /

+0.11 (+1.18%)

PVG Pretium Resources
$9.47 /

+0.11 (+1.18%)

Downgrade
FS KKR Capital downgraded to Neutral from Overweight at JPMorgan » 05:14
08/03/20
08/03
05:14
08/03/20
05:14
FSK

FS KKR Capital

$15.90 /

+0.01 (+0.06%)

JPMorgan analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSK FS KKR Capital
$15.90 /

+0.01 (+0.06%)

FSK FS KKR Capital
$15.90 /

+0.01 (+0.06%)

06/29/20 Compass Point
FS KKR Capital Corp. II initiated with a Buy at Compass Point
06/24/20 Raymond James
FS KKR Capital upgraded to Outperform from Market Perform at Raymond James
06/24/20 Raymond James
FS KKR Capital upgraded to Outperform from Market Perform at Raymond James
06/18/20 Wells Fargo
FS KKR Capital Corp. II initiated with an Underweight at Wells Fargo
FSK FS KKR Capital
$15.90 /

+0.01 (+0.06%)

Initiation
Yamana Gold initiated with a Buy at Peel Hunt » 05:14
08/03/20
08/03
05:14
08/03/20
05:14
AUY

Yamana Gold

$6.50 /

+0.145 (+2.28%)

Peel Hunt initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUY Yamana Gold
$6.50 /

+0.145 (+2.28%)

AUY Yamana Gold
$6.50 /

+0.145 (+2.28%)

07/24/20 Credit Suisse
Credit Suisse backs Outperform on Yamana Gold after Q2 results
07/20/20 Scotiabank
Yamana downgraded to Sector Perform on valuation at Scotiabank
07/20/20 Scotiabank
Yamana Gold downgraded to Sector Perform from Outperform at Scotiabank
05/22/20 National Bank
Yamana Gold downgraded to Sector Perform from Outperform at National Bank
AUY Yamana Gold
$6.50 /

+0.145 (+2.28%)

AUY Yamana Gold
$6.50 /

+0.145 (+2.28%)

AUY Yamana Gold
$6.50 /

+0.145 (+2.28%)

Upgrade
Qualcomm upgraded to Outperform from Market Perform at Bernstein » 05:13
08/03/20
08/03
05:13
08/03/20
05:13
QCOM

Qualcomm

$105.56 /

-1.605 (-1.50%)

Bernstein analyst Stacy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QCOM Qualcomm
$105.56 /

-1.605 (-1.50%)

QCOM Qualcomm
$105.56 /

-1.605 (-1.50%)

07/31/20
Fly Intel: Top five analyst upgrades
07/31/20 Edward Jones
Qualcomm upgraded to Hold on Huawei settlement at Edward Jones
07/31/20 Edward Jones
Qualcomm upgraded to Hold from Sell at Edward Jones
07/30/20 RBC Capital
Qualcomm price target raised to $106 from $81 at RBC Capital
QCOM Qualcomm
$105.56 /

-1.605 (-1.50%)

QCOM Qualcomm
$105.56 /

-1.605 (-1.50%)

QCOM Qualcomm
$105.56 /

-1.605 (-1.50%)

QCOM Qualcomm
$105.56 /

-1.605 (-1.50%)

Downgrade
Euronext downgraded to Equal Weight from Overweight at Barclays » 05:12
08/03/20
08/03
05:12
08/03/20
05:12
EUXTF

Euronext

$0.00 /

+ (+0.00%)

Barclays analyst Michalis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EUXTF Euronext
$0.00 /

+ (+0.00%)

07/07/20 Morgan Stanley
Euronext price target raised to EUR 104.40 from EUR 95.40 at Morgan Stanley
07/06/20 Deutsche Bank
Euronext price target raised to EUR 95 from EUR 94 at Deutsche Bank
06/04/20 Deutsche Bank
Euronext price target raised to EUR 94 from EUR 87 at Deutsche Bank
05/20/20 JPMorgan
Euronext price target raised to EUR 95 from EUR 87 at JPMorgan
Downgrade
SolarEdge downgraded to Market Perform from Outperform at JMP Securities » 05:12
08/03/20
08/03
05:12
08/03/20
05:12
SEDG

SolarEdge

$174.88 /

+0.02 (+0.01%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEDG SolarEdge
$174.88 /

+0.02 (+0.01%)

SEDG SolarEdge
$174.88 /

+0.02 (+0.01%)

07/27/20 Roth Capital
SolarEdge price target raised to $190 from $140 at Roth Capital
06/24/20 Goldman Sachs
SolarEdge downgraded to Sell from Neutral at Goldman Sachs
06/15/20 GLJ Research
Solar space earnings likely cut through remainder of 2020, says GLJ Research
06/04/20 GLJ Research
GLJ Research sees potential for SolarEdge margins to fall further through 2020
SEDG SolarEdge
$174.88 /

+0.02 (+0.01%)

SEDG SolarEdge
$174.88 /

+0.02 (+0.01%)

SEDG SolarEdge
$174.88 /

+0.02 (+0.01%)

Downgrade
Lanxess downgraded to Hold from Buy at Societe Generale » 05:11
08/03/20
08/03
05:11
08/03/20
05:11
LNXSF

Lanxess

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LNXSF Lanxess
$0.00 /

+ (+0.00%)

07/08/20 UBS
Lanxess price target raised to EUR 48 from EUR 43 at UBS
07/07/20 Goldman Sachs
Lanxess downgraded to Sell from Neutral at Goldman Sachs
06/17/20 Barclays
Lanxess price target raised to EUR 51 from EUR 48 at Barclays
06/05/20 Deutsche Bank
Deutsche Bank sees next quarters highlighting Lanxess' defensive elements
Downgrade
Unite Group downgraded to Hold from Buy at Panmure Gordon » 05:10
08/03/20
08/03
05:10
08/03/20
05:10
UTGPF

Unite Group

$0.00 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UTGPF Unite Group
$0.00 /

+ (+0.00%)

07/10/20 Stifel
Unite Group upgraded to Buy from Hold at Stifel
07/07/20 Peel Hunt
Unite Group upgraded to Add from Hold at Peel Hunt
07/01/20 Stifel
Unite Group downgraded to Hold from Buy at Stifel
06/26/20 Barclays
Unite Group price target raised to 1,090 GBp from 1,065 GBp at Barclays
Upgrade
Caterpillar upgraded to Neutral from Underweight at Atlantic Equities » 05:09
08/03/20
08/03
05:09
08/03/20
05:09
CAT

Caterpillar

$132.88 /

-3.75 (-2.74%)

Atlantic Equities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAT Caterpillar
$132.88 /

-3.75 (-2.74%)

CAT Caterpillar
$132.88 /

-3.75 (-2.74%)

07/24/20 Stifel
Caterpillar price target raised to $150 from $135 at Stifel
07/08/20
Fly Intel: Top five analyst upgrades
07/08/20 BofA
Herc Holdings upgraded to Buy, Caterpillar upgraded to Neutral at BofA
07/08/20 BofA
Caterpillar upgraded to Neutral from Underperform at BofA
CAT Caterpillar
$132.88 /

-3.75 (-2.74%)

CAT Caterpillar
$132.88 /

-3.75 (-2.74%)

CAT Caterpillar
$132.88 /

-3.75 (-2.74%)

CAT Caterpillar
$132.88 /

-3.75 (-2.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.